BPC-157 vs GLOW: One Peptide or Three, and Which One Fits

Every figure is an all-in monthly price covering the medication, physician review, refill management and shipping. There is no separate membership fee, and Pepti is cash-pay and does not bill insurance. Current pricing always lives on each product page.

What the numbers show

Three things stand out. First, a GLOW dose carries more BPC-157 than a BPC-157-only dose, 0.5 mg against 0.18 mg, because GLOW holds BPC-157 at twice the concentration and is drawn at a larger volume. That is a difference in the prescribing standard of each vial, not evidence that one amount works better: there is no human dose study of injectable BPC-157 at any amount. Second, GLOW is dosed five days a week and BPC-157 seven, and both vials are sized to last about four weeks. Third, the $50 difference buys GHK-Cu and TB-500; if you have no skin goal and no reason for TB-500, it buys components you do not need.

BPC-157 vs GLOW is not "weaker vs stronger"

GLOW is not a stronger BPC-157. It is a different prescription with a different purpose. No study has compared BPC-157 alone with GLOW, or with any combination of its components, in people or animals. A blend means one injection instead of several, at the cost of not knowing which component did what, and with fixed proportions that cannot be adjusted one component at a time.

GLOW has no regulatory status of its own; the FDA regulates the bulk substances a pharmacy compounds from, so the question is where each component stands. As of the FDA pages checked in September 2026:

In both July votes, the FDA's own scientists had proposed against inclusion, and the committee voted the other way. A committee vote is a recommendation, not a decision. None of the three is restricted, and all remain legal to prescribe and dispense as compounded medications. Compounded medications are not FDA approved, and neither BPC-157 nor GLOW is an FDA-approved drug. Are peptides FDA approved explains the difference.

Both are injected under the skin (subcutaneously) into the abdomen or thigh, rotating sites. You do not need to calculate anything: your directions are printed on the vial, and your physician sets them after reviewing your intake. Never carry a unit number from one vial to the other, because the concentrations differ. Refills run every 28 days, one vial per fill. Vials are multi-dose solutions shipped ready to use, refrigerated with ice packs, with sterile syringes and alcohol prep pads. GLOW's solution is blue from the copper in GHK-Cu, which is expected. The unit charts are in BPC-157 dosage and GLOW dosage.

Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.

For both, what gets reported is mostly at the injection site: redness, mild soreness, occasional bruising. Some people report early nausea or light-headedness. With GLOW, a faint blue-green mark at the site can appear from the copper in GHK-Cu and clears on its own. GLOW also brings GHK-Cu's copper cautions, which BPC-157 alone does not: anyone with Wilson's disease or another copper-metabolism disorder should not use it, and high-dose zinc competes with copper.

There is no established interaction list for either, because the trials that would produce one have not been run. Stop and contact your physician for any reaction that is severe or spreading. Swelling of the face, lips or throat, a widespread rash or difficulty breathing needs emergency care first: call 911, then tell your care team. The detail is in is BPC-157 safe and GLOW side effects.

There are no randomized controlled trials of injectable BPC-157 or of GLOW in humans, and no study has compared the blend with BPC-157 alone. BPC-157's evidence is rat tendon and gut work plus a two-week enema study reported only as an abstract. GLOW's evidence is per component: BPC-157's, GHK-Cu's topical skin studies and cell work, and TB-500's literature, which is almost entirely on the full-length protein. Physicians prescribe both on mechanism plus clinical experience. The accurate framing is "described in preclinical research and used clinically," not "shown to work in people." The claim-by-claim evidence is in BPC-157 benefits and GLOW benefits.

Neither can be bought legitimately without a prescription. Sites selling them "for research use only" are not accountable for what is in the vial: identity, purity, sterility and concentration are untested. The prescription route:

1. Complete a free online intake covering your history, medications and what you want help with.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
4. It ships refrigerated with your directions printed on the vial.
5. Your physician stays reachable for questions and dose changes.

Pepti prescribes both in every state except Oklahoma, plus DC Step-by-step pages: how to get BPC-157 prescribed online and how to get BPC-157 + TB-500 prescribed online.